Works matching IS 26662345 AND DT 2024 AND VI 7 AND IP 4


Results: 10
    1
    2
    3
    4
    5
    6
    7
    8

    Circulating Galectin-3: A Prognostic Biomarker in Hepatocellular Carcinoma.

    Published in:
    Journal of Immunotherapy & Precision Oncology, 2024, v. 7, n. 4, p. 255, doi. 10.36401/JIPO-24-6
    By:
    • Chamseddine, Shadi;
    • Yavuz, Betul Gok;
    • Mohamed, Yehia I.;
    • Lee, Sunyoung S.;
    • Yao, James C.;
    • Zishuo Ian Hu;
    • LaPelusa, Michael;
    • Lianchun Xiao;
    • Ryan Sun;
    • Morris, Jeffrey S.;
    • Hatia, Rikita I.;
    • Hassan, Manal;
    • Duda, Dan G.;
    • Diab, Maria;
    • Mohamed, Amr;
    • Nassar, Ahmed;
    • Amin, Hesham M.;
    • Kaseb, Ahmed Omar
    Publication type:
    Article
    9
    10

    A Phase Ib Study of Selinexor in Combination with Pembrolizumab in Patients with Metastatic Melanoma.

    Published in:
    Journal of Immunotherapy & Precision Oncology, 2024, v. 7, n. 4, p. 247, doi. 10.36401/JIPO-24-3
    By:
    • Gouda, Mohamed A.;
    • Stephen, Bettzy;
    • Tian, Yanyan;
    • Alshawa, Anas;
    • Onwugaje, Dilichukwu O. Chudy;
    • Albittar, Aya;
    • Yali Yang;
    • Zarifa, Abdulrazzak;
    • Yilmaz, Bulent;
    • Gurses, Serdar;
    • Sprenger, Ashabari;
    • Derbala, Mohamed H.;
    • Brink, Amanda;
    • How, Jeffrey Andrew;
    • Moyers, Justin;
    • Piha-Paul, Sarina A.;
    • Hong, David S.;
    • Meric-Bernstam, Funda;
    • Patel, Sapna P.;
    • Oliva, Isabella Glitza
    Publication type:
    Article